Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51

United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

13 insiders · 53 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$54.63M (5)

—

+$54.63M

53,951,010

27.38%

$285.40M

+19.5%

GSK plc entity

10% owner

$27.93M (1)

—

+$27.93M

18,245,691

9.26%

$96.52M

+8.8%

Chris Francis

See Remarks

—

$7.10M (14) scheduled

−$7.10M

61,867

0.0314%

$327.28K

—

Kyle Moran

Chief Financial Officer

—

$4.15M (7) scheduled

−$4.15M

134,385

0.0682%

$710.90K

+834.3%

Aik Na Tan

Director

—

$1.83M (9) scheduled

−$1.83M

35,668

0.0181%

$188.68K

+121.3%

Christian O Henry

Director

—

$1.37M (4) scheduled

−$1.37M

23,400

0.0119%

$123.79K

+45.2%

Adrian Rawcliffe

Director

—

$806.60K (3) scheduled

−$806.60K

10,700

0.0054%

$56.60K

−33.6%

Gregory L. Verdine

Director

—

$269.46K (2) scheduled

−$269.46K

275,917

0.1400%

$1.46M

+498.3%

Heidi L Wagner

Director

—

$231.07K (3) scheduled

−$231.07K

55,630

0.0282%

$294.28K

+72.6%

Mark Corrigan

Director

—

$217.30K (2) scheduled

−$217.30K

39,515

0.0201%

$209.03K

+22.6%

Paul Bolno

President and CEO

—

$140.96K (1)

−$140.96K

275,520

0.1398%

$1.46M

+2.6%

Chandra Vargeese

See Remarks

—

$43.42K (1)

−$43.42K

408,246

0.2072%

$2.16M

+113.6%

Ken Takanashi

Director

—

$23.22K (1) scheduled

−$23.22K

19,243,595

9.77%

$101.80M

+25.5%